摘要
目的探讨高血压性脑出血患者在应用颅内血肿微创穿刺清除术治疗过程中的临床效果。方法回顾性选取2023年1月—2024年3月北京中医药大学房山医院收治的100例高血压性脑出血患者的临床资料,按照治疗方式不同分为对照组(药物保守治疗)和治疗组(药物保守治疗的基础上采用颅内血肿微创穿刺清除术),各50例。比较两组临床疗效、血肿量、格拉斯哥昏迷评分(Glasgow Coma Scale,GCS)、美国国立卫生研究院卒中量表(National Institute of Health Stroke Scale,NIHSS)、日常生活能力评分(Barthel Index,BI)及并发症。结果两组患者治疗有效率比较,治疗组高于对照组,差异有统计学意义(P<0.05)。治疗2周后,两组患者血肿量较治疗前减少、GCS评分较治疗前升高,且治疗组(23.33±1.57)mL少于对照组的(28.67±7.14)mL、(14.26±0.07)分高于对照组的(14.00±0.08)分,差异均有统计学意义(t=24.509,17.294;P均<0.05)。治疗2周与出院3个月后,两组患者的NIHSS评分均下降,BI评分均升高,且治疗组NIHSS评分(6.22±4.14)分、(3.39±3.11)分低于对照组的(8.91±3.85)分、(7.70±3.96)分,BI评分(46.39±20.05)分、(52.50±22.90)分高于对照组的(35.00±18.36)分、(39.78±21.13)分,差异均有统计学意义(t=3.364,6.052,2.962,2.886;P均<0.05)。两组患者并发症发生率比较,治疗组较对照组低,差异有统计学意义(P<0.05)。结论颅内血肿微创穿刺清除术应用于高血压脑出血患者,能改善神经功能缺损表现与日常生活能力,预防并发症,值得借鉴。
Objective To explore the clinical effect of minimally invasive puncture and removal of intracranial hema-toma in patients with hypertensive cerebral hemorrhage.Methods The clinical data of 100 patients with hypertensive cerebral hemorrhage admitted to Fangshan Hospital of Beijing University of Chinese Medicine from January 2023 to March 2024 were retrospectively selected.According to the different treatment methods,they were divided into control group(drug conservative treatment)and treatment group(minimally invasive puncture and removal of intracranial he-matoma on the basis of drug conservative treatment),50 cases in each group.The clinical efficacy,hematoma volume,Glasgow Coma Scale(GCS),National Institute of Health Stroke Scale(NIHSS),Barthel Index(BI)and complications were compared between the two groups.Results The effective rate of the treatment group was higher than that of the control group,and the difference was statistically significant(P<0.05).After 2 weeks of treatment,the hematoma vol-ume of the two groups was lower than that before treatment,the GCS score was higher than that before treatment,and the treatment group(23.33±1.57)mL was less than the control group(28.67±7.14)mL,the score was 14.26±0.07,which was higher than 14.0±0.08 of the control group,the differences were statistically significant(t=24.509,17.294;all P<0.05).After 2 weeks of treatment and 3 months after discharge,the NIHSS scores of the two groups decreased,and the BI scores increased.The NIHSS scores of the treatment group were 6.22±4.14 and 3.39±3.11,which were lower than 8.91±3.85,7.70±3.96 of the control group,and the BI scores were 46.39±20.05 and 52.50±22.90,which were higher than 35.00±18.36,39.78±21.13 of the control group,and the differences were statistically significant(t=3.364,6.052,2.962,2.886;all P<0.05).The incidence of complications in the treatment group was lower than that in the control group,and the difference was statistically significant(P<0.05).Conclusion The application of minimally invasive puncture and removal of intracranial hematoma in patients with hypertensive cerebral hemorrhage can im-prove the performance of neurological deficits and daily living ability,and prevent complications.It is worth learning.
作者
颜家华
张大伟
张莹
YAN Jiahua;ZHANG Dawei;ZHANG Ying(Department of Brain Diseases,Fangshan Hospital of Beijing University of Traditional Chinese Medicine,Beijing 102400,China)
出处
《系统医学》
2025年第12期59-62,70,共5页
Systems Medicine
关键词
颅内血肿微创穿刺清除术
高血压性脑出血
脑出血
Minimally invasive puncture and removal of intracranial hematoma
Hypertensive intracerebral cerebral hemorrhage
Cerebral hemorrhage
作者简介
颜家华(1979—),男,本科,主治医师,研究方向为脑血管病的临床研究。
